Mark Wiggins
Corporate Officer/Principal at VAXCYTE, INC.
Network origin in Mark Wiggins first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
126
| Public Company | Pharmaceuticals: Major | 126 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.
52
| Subsidiary | Pharmaceuticals: Major | 52 |
| Subsidiary | Pharmaceuticals: Major | 31 | |
| Public Company | Biotechnology | 21 | |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB)
17
| Extinct | Investment Managers | 17 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.
8
| Extinct | Biotechnology | 8 |
| Public Company | Pharmaceuticals: Major | 8 | |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA.
5
| Extinct | Pharmaceuticals: Major | 5 |
selectION, Inc.
 selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA.
4
| Holding Company | Biotechnology | 4 |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Wiggins via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Human Resources Officer Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Investor Relations Contact Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| REVVITY, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| STANDARD BIOTOOLS INC. | Medical Specialties | Director/Board Member Corporate Officer/Principal Chairman | |
| NUVASIVE, INC. | Medical Specialties | Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder Director/Board Member | |
| SANOFI | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
| GLOBUS MEDICAL, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Sales & Marketing President Corporate Officer/Principal | |
| CHIASMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree Director/Board Member Undergraduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
| UCB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| Suffolk University | College/University | Graduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| The University of Arkansas | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Santa Clara University | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree General Counsel | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Director/Board Member Chief Executive Officer Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Research Triangle Park | Corporate Officer/Principal Corporate Officer/Principal | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| CARGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member |
Statistics
International
| United States | 46 |
| Ireland | 2 |
| France | 2 |
| Belgium | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 37 |
| Consumer Services | 12 |
| Consumer Non-Durables | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 571 |
| Corporate Officer/Principal | 271 |
| Independent Dir/Board Member | 178 |
| Chairman | 93 |
| Undergraduate Degree | 85 |
Most connected contacts
| Insiders | |
|---|---|
| James Blair | 48 |
| Heath Lukatch | 43 |
| Arda Minocherhomjee | 34 |
| William Young | 32 |
| Kurt C. Wheeler | 28 |
| Louis C. Bock | 27 |
| Stelios Papadopoulos | 26 |
| James Tobin | 26 |
| Sylvie Grégoire | 25 |
| William Rastetter | 24 |
| Cam Gallagher | 24 |
| Burt Adelman | 23 |
| Peter Kellogg | 21 |
| Mary L. Good | 21 |
| Ted Wang | 20 |
- Stock Market
- Insiders
- Mark Wiggins
- Company connections
